TPST
Tempest Therapeutics Inc
NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY
$1.74
+2.96% today
Updated 2026-04-29
Market cap
$24.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.33
Dividend yield
—
52W range
$2 – $12
Volume
0.2M
Tempest Therapeutics Inc (TPST) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $9.73M | $277000.00 | $653000.00 | $295000.00 | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | -97.2% | +135.7% | -54.8% | -100.0% | — | — | — | — | — | — | — |
| Cost of revenue | — | $93000.00 | $231000.00 | $450000.00 | $2.25M | $5.40M | $28000.00 | $32000.00 | $1.05M | $815000.00 | $1.27M | $1.81M | $381000.00 | $389000.00 | — |
| Gross profit | — | — | — | $9.73M | $-1.97M | $-4.75M | $267000.00 | $-32000.00 | $-1.05M | $-815000.00 | $-1.27M | $-1.81M | $-381000.00 | $-389000.00 | — |
| Gross margin | — | — | — | 100.0% | -711.9% | -727.1% | 90.5% | — | — | — | — | — | — | — | — |
| R&D | $1.17M | $6.32M | $15.80M | $21.78M | $18.43M | $21.64M | $14.53M | $14.43M | $27.84M | $14.39M | $17.17M | $22.53M | $17.50M | $28.48M | $12.61M |
| SG&A | — | $7.21M | $13.33M | $26.15M | $51.59M | $49.22M | $27.74M | $8.69M | $17.56M | $4.91M | $9.82M | $12.11M | $11.66M | $13.55M | $13.97M |
| Operating income | $-2.62M | $-13.53M | $-29.13M | $-47.93M | $-72.00M | $-81.01M | $-20.48M | $-23.12M | $-45.40M | $-19.30M | $-26.99M | $-34.64M | $-29.16M | $-42.03M | $-26.57M |
| Operating margin | — | — | — | -492.4% | -25992.4% | -12406.1% | -6943.1% | — | — | — | — | — | — | — | — |
| EBITDA | $-2.62M | $-13.44M | $-28.81M | $-49.07M | $-71.86M | $-79.82M | $-84.27M | $-27.01M | $-43.52M | $-18.39M | $-26.65M | $-33.45M | $-27.66M | $-40.14M | $-25.79M |
| EBITDA margin | — | — | — | -504.1% | -25941.5% | -12223.7% | -28566.1% | — | — | — | — | — | — | — | — |
| EBIT | — | $-13.53M | $-29.04M | $-49.52M | $-73.14M | $-82.06M | $-84.30M | $-27.04M | $-44.57M | $-19.21M | $-27.02M | $-34.09M | $-28.04M | $-40.53M | $-26.05M |
| Interest expense | — | $0.00 | $0.00 | $0.00 | $436000.00 | $659000.00 | $0.00 | $134000.00 | $1.04M | $507000.00 | $1.28M | $1.62M | $1.45M | $1.32M | $207000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.73M | $-13.51M | $-29.04M | $-49.52M | $-73.22M | $-82.26M | $-84.58M | $-27.19M | $-44.57M | $-19.12M | $-28.30M | $-35.71M | $-29.49M | $-41.84M | $-26.26M |
| Net income growth (YoY) | — | -395.8% | -115.0% | -70.5% | -47.9% | -12.3% | -2.8% | +67.8% | -63.9% | +57.1% | -48.0% | -26.2% | +17.4% | -41.9% | +37.2% |
| Profit margin | — | — | — | -508.7% | -26432.9% | -12597.2% | -28670.5% | — | — | — | — | — | — | — | — |